BRAVACCINI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 290
EU - Europa 236
AS - Asia 197
AF - Africa 37
Totale 760
Nazione #
US - Stati Uniti d'America 287
SG - Singapore 109
IT - Italia 75
CN - Cina 56
DE - Germania 31
GB - Regno Unito 29
CI - Costa d'Avorio 27
FI - Finlandia 23
SE - Svezia 20
RU - Federazione Russa 17
VN - Vietnam 12
IE - Irlanda 9
ID - Indonesia 8
IN - India 8
TG - Togo 7
BG - Bulgaria 5
FR - Francia 5
AT - Austria 4
NL - Olanda 4
CA - Canada 3
CZ - Repubblica Ceca 3
CH - Svizzera 2
EE - Estonia 2
TR - Turchia 2
ZA - Sudafrica 2
BE - Belgio 1
HK - Hong Kong 1
LT - Lituania 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
UA - Ucraina 1
Totale 760
Città #
Singapore 93
Santa Clara 71
Southend 28
Abidjan 27
Boardman 23
Chandler 20
Ashburn 19
Helsinki 19
Fairfield 16
Dublin 9
Bologna 8
Jakarta 8
Princeton 8
Woodbridge 8
Houston 7
Lomé 7
Seattle 6
New York 5
Rome 5
Sofia 5
Wilmington 5
Falkenstein 4
Frankfurt am Main 4
Guangzhou 4
Lappeenranta 4
Milan 4
Nuremberg 4
Berlin 3
Bremen 3
Brno 3
Cambridge 3
Imola 3
Shanghai 3
Springfield 3
Turin 3
Verona 3
Westminster 3
Xi'an 3
Yubileyny 3
Beijing 2
Bern 2
Carpi 2
Catanzaro 2
Changsha 2
Fort Worth 2
Frattamaggiore 2
Fuzhou 2
Hangzhou 2
Monticello d'Alba 2
Monzuno 2
Naples 2
Qingdao 2
Redwood City 2
Saint Petersburg 2
Senago 2
Toronto 2
Abeokuta 1
Amsterdam 1
Ann Arbor 1
Bagnacavallo 1
Bangkok 1
Baoding 1
Boston 1
Boydton 1
Brussels 1
Bühl 1
Central 1
Changchun 1
Changzhou 1
Chengdu 1
Cirò Marina 1
Colleferro 1
Des Moines 1
Dongguan 1
Florence 1
Foshan 1
Harbin 1
Hyderabad 1
Istanbul 1
Jiaxing 1
Jinan 1
Lisbon 1
London 1
Luxembourg 1
Medford 1
Miami 1
Modena 1
Mülheim 1
Nanjing 1
Nantong 1
Ningbo 1
Ottawa 1
Padova 1
Parma 1
Pizzo 1
Prineville 1
Pune 1
Rimini 1
San Diego 1
Savignano sul Rubicone 1
Totale 535
Nome #
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data 105
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients 98
Cancer region detection by visual features in histopathology 88
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus 78
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 53
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer 34
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 33
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 32
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 31
Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon 28
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer 28
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 27
Why the complications of COVID-19 patients differ in elderly and young cancer patients 24
PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis 24
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 19
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations 18
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? 18
Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter 16
Sorafenib for the treatment of breast cancer 13
Are we ready to use TMB in breast cancer clinical practice? 12
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer 12
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? 11
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 11
Totale 813
Categoria #
all - tutte 3.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 7 5 7 3 3
2020/202148 9 2 2 0 1 2 0 11 4 0 2 15
2021/202258 2 1 2 2 5 2 1 4 4 4 18 13
2022/2023113 8 17 6 11 5 16 1 5 22 0 8 14
2023/2024112 6 10 14 7 1 12 4 4 33 8 8 5
2024/2025417 42 86 57 43 107 34 23 25 0 0 0 0
Totale 813